Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Apremilast

Various toxicities: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wakiya R, et al. Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behcet's disease. Dermatologic Therapy 35: No. 8, et al. Jun 2022. Available from: URL: http://doi.org/10.1111/dth.15616 Wakiya R, et al. Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behcet's disease. Dermatologic Therapy 35: No. 8, et al. Jun 2022. Available from: URL: http://​doi.​org/​10.​1111/​dth.​15616
Metadaten
Titel
Apremilast
Various toxicities: 3 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41739-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pemetrexed

Case report

Multiple drug

Case report

Infliximab